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1. Introduction 
Multiple sclerosis (MS) is a chronic progressive disease associated with both sensory-motor 
and psychological symptoms including cognitive deficits, affective disturbances, and 
fatigue. Intellectual disability of MS patients usually manifests itself as a composition of 
subtle deficits in certain cognitive domains detectable with sensitive neuropsychological test 
batteries specially developed for the MS population (Benedict et al., 2006b; Rao, 1990). 
Nevertheless, the effect of cognitive impairment on everyday life activities, employment 
status, and social relationships is considerable (Amato et al., 1995; Rao et al., 1991b). 
Cognitive impairment may occur in the earliest stages of the disease (Achiron & Barak, 2003; 
Callanan et al., 1989; Deloire et al., 2005; Feinstein et al, 1992; Glanz et al., 2007) even in 
patients with clinically isolated syndrome (CIS) (Achiron & Barak, 2003; Feuillet et al., 2007; 
Glanz et al., 2007; Potagas et al., 2008). Cognitive deficits may develop independently from 
physical disability particularly in the early stage of the disease and in patients with benign 
MS (Feuillet et al., 2007; Glanz et al., 2007; Portaccio et al., 2009). However, the presence of 
cognitive decline has been found to predict a more progressive disease course (Portaccio et 
al., 2009; Zipoli et al., 2010). Detrimental effects on quality of life and poor disease prognosis 
underlie the importance of neuropsychological assessment of MS patients in clinical 
practice. 
Magnetic resonance imaging (MRI) is one of the most important paraclinical tools used in 
the diagnosis of MS. Quantitative measures derived from conventional and advanced MRI 
methods have been developed to monitor and predict the course of the disease, as well as 
for in-vivo non-invasive investigation of MS pathophysiology (Filippi & Rocca, 2010). 
Increasing recognition of the functional relevance and prognostic role of MS cognitive 
impairments has resulted in focused attention on MR correlates of cognitive deficit. 
Assessment of the global and regional white matter (WM) lesion burden, derived from T2- 
or T1-weighted MRI shows modest association with cognitive status (Arnett et al., 1994; 
Hohol, et al., 1997; Patti et al., 2009; Rao et al., 1989; Rovaris et al., 2001; Swirsky-Sacchetti et 
al., 1992). A stronger relationship has been obtained with quantification of the whole and 
www.intechopen.com
 
Neuroimaging – Clinical Applications 
 
356 
regional brain atrophy (Rovaris, et al., 2006; Zivadinov, et al., 2001) considered as a marker 
of irreversible tissue loss (Miller et al., 2002; Rovaris & Filippi, 1999). Non-conventional MRI 
techniques assessing diffuse brain tissue damage outside of the MRI-visible lesions provide 
potent tools to detect pathological changes underlying MS cognitive deficits than lesion-
based and atrophy measures (Filippi et al., 2010). 
Recent advances in histopathological and imaging techniques have renewed the 
appreciation of gray matter (GM) involvement in MS (Pirko et al., 2007). New 
histopathological methods have found demyelinating lesions in significant portions of the 
cortex (Albert et al., 2007; Bo et al., 2003; Kidd et al., 1999; Kutzelnigg et al., 2005; Peterson et 
al., 2001; Wegner et al., 2006). In addition, neuroimaging techniques have detected structural 
changes in the GM (Pirko et al., 2007). In this review, we summarize the results of recent 
studies correlating MRI-detectable GM abnormalities with various aspects of MS 
neuropsychological dysfunction. 
2. Gray matter pathology in multiple sclerosis 
GM pathology is detectable in the earliest disease stages (Chard et al., 2004; De Stefano et al., 
2003; Kutzelnigg et al., 2005), and becomes prominent in the progressive phase (Fisniku et 
al., 2008; Kutzelnigg et al., 2005). 
GM damage in MS may result from primary local cortical demyelinating lesions (Bo et al., 
2003; Peterson et al., 2001), and from GM atrophy secondary to axonal transections in 
destructive WM plaques or severe diffuse axonal damage in the normal-appearing WM 
leading to Wallerian (anterograde or transsynaptic) degeneration, as well as retrograde 
degeneration (Evangelou et al., 2000; Sepulcre et al., 2009; Trapp et al., 1998). However, the 
exact relationship between primary and secondary processes leading to GM damage 
remains poorly understood. Finally, other primary neurodegeneration independent from 
focal WM or GM lesions has been presumed in the early development of GM atrophy in MS 
(Sepulcre et al., 2009). 
MS is characterized by a significant number of focal cortical lesions (CLs) (Bo et al., 2003; 
Kidd et al., 1999; Kutzelnigg et al., 2005; Peterson et al., 2001). In addition, demyelination 
may occur in the deep GM structures, hippocampus, hypothalamus, cerebellum, and spinal 
cord (Geurts et al., 2009). Pathologically, CLs are characterized by a much milder 
lymphocyte infiltration, complement deposition, microglial activation, and blood-brain 
barrier disruption than WM lesions (Bo et al., 2003). Cortical demyelinisation can occur in 
conjunction with subcortical WM plaques or as small perivascular intracortical lesions. 
However, the most extensive cortical demyelination is seen as widespread and band-like 
subpial lesions, which span the cortex over long distances affecting several adjacent gyri and 
sulci. This type of CL is associated with chronic inflammation of the meninges (Kooi et al., 
2009; Magliozzi et al., 2007). 
3. Cognitive impairment in multiple sclerosis 
3.1 General intellectual abilities 
The estimated prevalence of cognitive impairment in MS ranges between 43 to 70% 
(Benedict et al., 2006b; Rao et al., 1991a) both in the earlier and later stages of the disease 
(Beatty et al., 1990; Piras et al., 2003). Cognitive impairment can be seen irrespective of 
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the duration of the disease and is only mildly associated with physical disability (Patti et 
al., 2009). However, cognitive disturbances seem to be more severe in patients with 
chronic progressive disease compared to those in the relapsing-remitting (RR) stage 
(Patti et al., 2009). Both fatigue and depression have been identified as important 
contributors to cognitive impairment of MS patients (Arnett et al., 2008; Deluca et al., 
2004). 
MS affects various aspects of general cognitive functioning, including efficiency of 
information processing, verbal and visuo-spatial memory, executive functioning, attention, 
and visual perceptual processing. Processing speed, and visual learning and memory seem 
to be most commonly affected (Benedict et al., 2006b; Rao et al., 1991a). 
3.2 Social cognition, Theory of Mind 
Deficits of general intellectual abilities significantly interfere with everyday life activities 
and decision-making. In addition, loss of employment status, restriction in social 
activities, and difficulties in inter-personal relationships frequently occur during the 
disease. Deficits of social cognition may additionally account for all of these functional 
limitations. Social cognition is a human mental ability involving the capacity to interpret 
and predict mental states of other people in terms of thoughts, intentions, desires and 
beliefs known as Theory of Mind (ToM), also referred as mentalizing and mindreading. 
ToM ability involves social-perceptual processes that enable mental state decoding from 
nonverbal cues, such as facial expression, eye gaze, and body postures. Furthermore, ToM 
involves social cognitive processes that enable complex abstract reasoning about the 
mental state of others, such as prosody and social content of speech (Stone et al., 1998). 
Social cognition might be independent, and dissociable from general intelligence 
(Shamay-Tsoory et al., 2005). Only a few studies investigated social cognition in MS; all 
demonstrated deficits in facial emotion recognition (Banati et al., 2010; Henry et al., 2009; 
Jehna et al., 2010; Krause et al., 2009; Ouellet et al., 2010) In addition, decline in complex 
cognitive inferences relating to the content of the mental state was also described (Banati 
et al., 2010; Ouellet et al., 2010). 
The neural basis of ToM abilities has been widely investigated using advanced 
neuroimaging methods in healthy subjects and in several clinical conditions showing 
social cognitive impairment particularly in high-functioning autism and schizophrenia. 
These studies support the hypothesis that integrated fronto-temporal and temporo-
parietal circuits are dedicated to mentalizing. Main nodes of these networks were found 
distributed in the posterior superior temporal sulcus, temporo-parietal junction, temporal 
pole, medial prefrontal cortex, anterior cingulate cortex, orbitofrontal cortex, and inferior 
parietal lobule, as well as in subcortical areas, particularly in the amygdala (Adolphs et 
al., 2002; Frith & Frith, 2006; Stone, et al., 1998). Another important neural mechanism 
participating in social cognitive processes is the activation of mirror neurons during 
observation of movements of others (Williams, 2008). Mirror neuron activation described 
first in macaque monkeys produces inner simulation of the viewed action thereby 
enabling the understanding of its intended goal. Electrophysiological studies of monkeys 
and human functional MRI (fMRI) studies found mirror neurons in the premotor cortex 
(frontal mirror system), as well as in the inferior parietal cortex and posterior temporal 
cortex (parietal mirror system) (Williams, 2008). 
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4. Relationship between gray matter findings assessed by MRI and cognitive 
dysfunction in multiple sclerosis 
4.1 General intellectual function 
4.1.1 Neocortical lesions 
In vivo visualization of CLs is challenging (Geurts et al., 2005a) because CLs are typically 
small compared to the usual resolution of MRI in clinical practice, have poor contrast with 
the surrounding normal GM, and have similar signal properties to those of cerebrospinal 
fluid (CSF) reducing their conspicuity in boundary areas of GM and CSF. Using 
conventional imaging techniques, CLs are missed in up to 95% of the cases (Geurts et al., 
2005b). In the past few years, large efforts have been devoted to the development of MRI 
techniques capable of visualizing at least a portion of CLs in vivo (Bagnato et al., 2006; 
Geurts et al., 2005a; Kangarlu et al., 2007; Mainero et al., 2009; Mike et al., 2011; Nelson 
Poonawalla et al., 2008; Nelson et al., 2007; Simon et al., 2010). Novel MRI methods have 
been deployed to address these challenges, including novel pulse sequences, multi-channel 
and high-resolution imaging, and ultra-high magnetic field strength (Bagnato et al., 2006; 
Kangarlu et al., 2007; Mainero et al., 2009; Mike et al., 2011; Nelson et al., 2008; Nelson et al., 
2007; Simon et al., 2010). Recently, the application of the double inversion recovery (DIR) 
sequence convincingly demonstrated that CLs are frequent in MS patients (Calabrese et al., 
2007; Calabrese et al., 2008), as has been long known from pathological studies (Brownell & 
Hughes, 1962, Lumsden, 1970). 
We employed a high-resolution 3 Tesla brain MRI protocol that combined multiplanar 
display of 3 dimensional (3D) fluid attenuated inversion recovery (FLAIR) and T1-weighted 
3D inversion recovery spoiled gradient-recalled echo (IR-SPGR) sequences to study the 
relationship between CLs and cognitive performance of MS patients (Mike et al., 2011). This 
approach took advantage of the high contrast sensitivity of FLAIR for imaging CLs 
combined with IR-SPGR to delineate the boundary between cortex and WM (Figure 1.). 
These sequences are widely available on clinical scanners from multiple vendors and can be 
integrated in clinical routine with reasonable scan times. Using this clinically applicable MRI 
method the detected CL load was comparable with the bulk of CLs assessed by specialized 
MRI methods developed for sensitive CL delineation (Calabrese et al., 2008; Mainero et al., 
2009; Nelson et al., 2008; Nelson et al., 2007; Simon et al., 2010). 
We explored the relationship between cognitive performance and lesion load of the WM and 
cortical GM compartments in an MS patient cohort including RR (n=20) and secondary 
progressive (SP) (n=6) clinical subtypes. Very few studies have examined this previously 
(Bagnato et al., 2010; Calabrese et al., 2009; Roosendaal et al., 2009). Therefore, a broad range 
of neuropsychological variables, which could potentially include cortical contributions (e.g. 
information processing speed, new learning, verbal and non-verbal memory, executive 
function) had been assessed. After controlling for age, depression and pre-morbid 
intelligence, CL number, CL volume and WM lesion volume independently predicted the 
performance of information processing speed and working memory. In addition, CL 
number also predicted verbal learning and memory. 
These findings suggested that both WM and GM lesions influence cognitive performance in 
MS. However, CLs may have a particularly important contribution to this relationship, as 
beside information processing speed performance, CL number also significantly correlated 
with verbal learning abilities. Two recent studies using DIR sequence yielded similar results 
(Calabrese et al., 2009; Roosendaal et al., 2009). 
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Fig. 1. Cortical lesion shown on multiplanar images 
The same cortical lesion involving both the cortex and the adjoining subcortical white matter 
(Type I lesion) is shown on FLAIR (upper row) and IR-SPGR (lower row) images (arrows), 
reconstructed in sagittal, axial, and coronal planes. Note that the lesion is conspicuous on 
FLAIR, while the anatomic location relative to the white matter-gray matter boundary is 
well defined on the IR-SPGR images. 
4.1.2 T2 hypointensity imaging 
Iron deposition, a possible sign of neurodegeneration, reduces T2 relaxation times, resulting 
in hypointensity on T2-weighted images. In MS, T2 hypointensity frequently occurs in the 
thalamus and basal ganglia. T2 hypointense regions in the GM have been shown to correlate 
with cognitive impairment of MS patients (Brass et al., 2006; Neema et al., 2007). 
4.1.3 Gray matter atrophy 
Several cross-sectional and longitudinal studies have reported GM volume reduction in MS 
using manual or semi-automated segmentation methods, voxel-based morphometry (VBM) 
approach, and cortical thickness measurement (Grassiot et al., 2009). GM atrophy has been 
documented both in the deep gray matter structures (caudate nucleus, thalamus) and in 
neocortical regions. Recently, the relationship between GM volume decrease and cognitive 
performance of MS patients has been intensively investigated. 
Neocortical volume has been found to be significantly reduced in cognitively impaired 
compared to cognitively preserved patients (Amato et al., 2004). Similar findings have been 
reported with cortical thickness analyses of the global brain and parcellated brain areas 
(Calabrese et al., 2010). Compared to healthy controls, a VBM study found significant 
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decrease in GM volume only in MS patients with cognitive impairment in contrast to 
patients with normal neuropsychological performance (Morgen et al., 2006). 
Neuropsychological performance of patients with cognitive decline has been documented to 
correlate with cortical brain volume (Amato et al., 2004; Benedict et al., 2006a; Morgen et al., 
2006), as well as cortical thickness (Calabrese et al., 2010). GM volume assessed 
longitudinally decreased more progressively in MS patients with deteriorating cognitive 
performance compared to patients with stable or improving cognitive state (Amato et al., 
2007). 
The relevance of cortical damage in cognitive dysfunction of MS patients has been 
highlighted by studies of regional cortical atrophy (Calabrese et al., 2010; Morgen et al., 
2006; Tekok-Kilic et al., 2007). In a group of cognitively impaired MS patients, GM volume 
of fronto-temporal brain areas presumed to be involved in neural processing of working 
memory, information processing, and divided attention correlated with performance on the 
paced auditory serial addition task (PASAT) test performance (Morgen et al., 2006). Using a 
semi-automated parcellation analysis of the neocortex, the prefrontal GM volume resulted 
the strongest predictor of memory and information processing performance in MS patients 
(Tekok-Kilic et al., 2007). 
Impact of subcortical GM atrophy on MS cognitive performance has also been established. 
Different methods applied for quantification of deep GM structures including the measure 
of the bicaudate ratio (Bermel et al., 2002), enlargement of the third ventricular width 
(Benedict et al. 2004a, 2004b, 2006a, Christodoulou et al., 2003; Sanchez et al, 2008; Tekok-
Kilic et al., 2007), semi-automated (Houtchens et al., 2007) and automated (Benedict et al. 
2009) segmentation of subcortical GM structures provided convergent evidence for a 
relationship between deep GM damage and neuropsychological impairment. Reduction of 
thalamic volume was found to be a reliable predictor of cognitive decline in MS even after 
correction for WM lesion volume, whole brain atrophy and third ventricular with (Benedict 
et al., 2009; Houtchens et al., 2007). Strong correlations have been reported between caudate 
atrophy and impaired information processing speed (Bermel et al., 2002), as well as verbal 
learning and memory (Benedict et al., 2009). Measure of the third ventricle width has been 
used to infer the atrophy of adjacent GM structures, such as the thalamus (central atrophy). 
Enlargement of the third ventricle showed a highly significant relationship with both 
general cognitive impairment and deficits in specific neuropsychological domains even after 
accounting for the influence of global lesion load measures and whole brain atrophy 
(Benedict et al., 2004b; Christodoulou et al., 2003; Sanchez et al., 2008). 
A recent study investigated the contribution of different GM compartments to cognitive 
dysfunction in MS patients, and found both the central and cortical atrophy predictive of the 
presence of cognitive impairment in MS (Tekok-Kilic et al., 2007). 
4.1.4 Non-conventional MRI methods 
Beyond focal lesions and atrophy, MS pathology is characterized by diffuse tissue damage. 
Conventional morphological MRI methods are insensitive to detect these microscopic 
structural alterations. Quantitative MRI techniques including magnetization transfer (MT) 
MRI, diffusion tensor imaging (DTI), and proton MR spectroscopy (1H-MRS) detect brain 
tissue changes on a molecular level, and thereby are able to measure the degree of structural 
integrity in diffusely affected brain tissue. Abnormalities in the GM assessed with non-
conventional MRI methods have been well established in MS (Filippi et al., 2010; Rovaris et 
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al., 2006). Studies, addressing the clinical relevance of diffuse GM pathology in the cognitive 
impairment of MS patients are summarized in the following subsections. 
4.1.4.1 Magnetization transfer MRI 
The MT ratio (MTR) derived from MT MRI reflects the capacity of macromolecules to 
exchange magnetization with surrounding water molecules and estimates the relative 
amounts of free and bound water in the brain (Wolff & Balaban, 1994). In MS, reduced MTR 
values may indicate a relative increase in the unbound water fraction due to edema and 
inflammation, or a reduction in the bound fraction, which may reflect demyelination and 
axonal loss (Schmierer et al., 2007). MTR values derived from the cortical/subcortical brain 
tissue were significantly lower in cognitively impaired patients than in those with no 
impairment (Rovaris, et al., 2000). MTR values of the cortical/subcortical regions showed 
correlation with cognitive performance of RR MS patients (Rovaris et al., 2000). In CIS 
patients, using voxel-by-voxel statistical mapping, significant correlations were observed 
between local MTR values and PASAT scores in the right Brodmann (BA) 4 and the left 
BA40 (Ranjeva et al., 2006; Ranjeva et al., 2005). A recent study investigated GM MRI 
correlates of cognitive impairment in different stages of MS. In patients with CIS 
suggestive for MS, mean cortical MTR has been identified as the only independent 
predictor of decreased mental processing speed. However, in early RR MS cortical 
atrophy was found as the strongest correlate of the same cognitive task. These findings 
suggest that both microscopic tissue disintegrations and atrophy of the cortex are 
important determinants of MS cognitive performance, however their significance changes 
with advance of the disease (Khalil et al., 2011). In a study including benign MS patients 
(BMS), total and regional (frontal, temporal, and occipital) cortical MTR values corrected 
for WM lesion volume were able to differentiate between cognitively impaired and 
cognitively preserved MS patients. However, MTR values of cognitively preserved MS 
patients did not differ from healthy controls. These findings support heterogeneity of the 
brain structural damage in BMS associating with different clinical prognosis (Amato et al., 
2008). In patients with primary progressive (PP) MS, significant correlations have been 
observed between decrease of MTR value in specific cortical regions (right inferior 
parietal cortex, right inferior occipital gyrus) and PASAT performance (Khaleeli et al., 
2007). In a longitudinal study of PP MS patients, GM MTR independently predicted 
PASAT score at the 5-year follow-up (Penny et al., 2010). 
4.1.4.2 Diffusion tensor imaging 
DTI measures the diffusion of water molecules in the brain tissue, which is directionally 
determined along the fiber tracts. Disturbances in the structural integrity of the brain tissue 
are reflected by the increase of the mean diffusivity (MD) and decrease of the fractional 
anisotrophy (FA), parameters derived from DTI technique (Rovaris et al., 2009). 
In RRMS, MD of the NAGM moderately correlated with neuropsychological tests 
measuring semantic fluency, and information processing-working memory (Rovaris et al., 
2002). Structural GM damage of BMS patients with cognitive impairment has been 
demonstrated in a study comparing GM MD between cognitively impaired BMS patients 
and SP MS patients. MD of the GM showed no difference between BMS patients with 
cognitive deficit and low physical disability and patients with SP disease course (Rovaris et 
al., 2008). 
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4.2 Mentalization 
4.2.1 Focal atrophy of the neocortex impairs mentalization ability of multiple sclerosis 
patients 
Living with MS frequently associates with disturbed social life including insufficiency in 
partnerships and family roles, as well as employment status (Halper, 2007). Intact social 
cognition is fundamental for successful social functioning (Penn et al., 1997). Recently, few 
studies investigating social cognitive abilities of MS patients have reported deficits in 
emotion recognition and complex perspective taking abilities (Banati et al., 2010; Henry et 
al., 2009; Jehna et al., 2010; Krause et al., 2009; Ouellet et al., 2010). 
To investigate the impact of cortical pathology on social cognitive dysfunction, we 
performed an MRI study in a cohort of 49 MS patients. We measured the cortical thickness 
throughout the whole brain, and analyzed its association with mentalization test 
performance to indentify cortical areas involved in neural integration processes of 
mentalization in MS. Performances on neuropsychological tests were corrected for 
confounding effects of anxiety and depression. Compared to healthy subjects, MS patients 
performed significantly poorer in verbal (Irony test) and visual (Eyes test) mentalization 
tasks. These results are in line with previous reports (Banati et al., 2010; Henry et al., 2009; 
Jehna et al., 2010; Krause et al., 2009; Ouellet et al., 2010). 
Cortical thickness was assessed to quantify cortical atrophy as thinning of the cortex. 
FreeSurfer software, version 4.5 (http://surfer.nmr.mgh.harvard.edu) was applied on 3 
Tesla 3D Magnetization Prepared Rapid Gradient Echo (MPRAGE) images for automated 
reconstruction and measure of cortical thickness characterized by preciosity within a 
submillimeter range (Dale et al., 1999; Fischl et al., 1999). After correcting for confounding 
effects of age on cortical thickness, and effects of depression and anxiety on mentalization 
significant correlations were found between the Eyes test performance and cortical thickness 
of several focal areas. The Eyes test is an advanced and sensitive tool to detect subtle 
dysfunctions in facial expression recognition (Baron-Cohen et al., 2001). In the Eyes test, 
participants are required to judge mental states from photographs portraying only the eye 
region of the face. The identified frontotemporal cortical areas showing significant 
correlation with the Eyes test were also reported in previous studies documenting a widely 
distributed brain network engaged in neural processes of facial emotion recognition 
(Adolphs et al., 2002; Frith & Frith, 2006; Sabatinelli et al., 2011). Simulation theory describes 
a presumed physiologic mechanism participating in the understanding of observed motor 
actions, motor learning, and mental state decoding as well as empathizing in social-
perceptual processes (Bastiaansen et al., 2009; Williams, 2008). Firing of mirror neurons in 
the brain of the observer simulates the neuronal activation pattern required to execute the 
observed movement, and thereby enables the understanding of the underlying action goal 
(Bastiaansen et al., 2009; Williams, 2008). Mirror neurons were identified in prefrontal and 
premotor areas, and in the parietal and temporal lobe (Bastiaansen et al., 2009; Williams, 
2008). In addition, recent studies found evidence on simulation of observed sensations and 
emotions through mirror neuron activation in the primary somatosensory cortex, anterior 
insula, and amygdala contributing to empathic understanding (Bastiaansen et al., 2009; 
Williams, 2008). Previous fMRI studies demonstrated that viewing emotional facial 
expressions associates with premotor cortex activation presuming a mirror neuron 
mechanism (Bastiaansen et al., 2009). Inner simulation of the observed facial muscle group 
contractions is linked to a matching affective state based on personal experiences. 
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In conclusion, our study suggests that GM pathology in cortical regions constituting neural 
networks processing high-level mental information significantly impact the mentalization 
ability in MS. 
4.2.2 Functional MRI study of mentalization in multiple sclerosis 
Neuroanatomical correlates of emotional face expression recognition deficit in MS were also 
investigated in an fMRI study. This approach identified decreased insular and ventrolateral 
prefrontal cortex BOLD activation in MS patients with impaired recognition performance 
compared to the unimpaired group (Krause et al., 2009). 
5. Conclusion 
Cognitive impairment in MS occurs frequently as mild deficit in different 
neuropsychological domains. Clinical impact of cognitive dysfunction emerges in every day 
life situations, employment status, and social environment compromising quality of life of 
the patients. Diagnostic evaluation of neuropsychological performance in MS has also been 
proved to be significant from prognostic point of view, as presence of cognitive impairment 
may predict worse disease course. Recently, involvement of the GM in pathological 
processes underlying MS has been convergent supported by histopathological and MRI 
studies. The impact of GM damage on clinical course of the disease and its relationship with 
WM lesions is under intensive research, in which application of different MRI methods 
plays a highly important role. Application of conventional structural MRI, and non-
conventional MRI techniques has been enabled to quantify GM pathology as atrophy, CL 
load, and degree of microscopic tissue integration disturbances. Cognitive impairment has 
been demonstrated to correlate all with these different aspects of GM damage highlighting 
the relevance of MRI evaluation of the GM in MS. Future studies are needed to further 
refine the MRI-cognition relationship to improve therapeutic decisions and prognosis of MS, 
and develop potential treatment strategies targeting neuroprotection. 
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